Related Experiment Video
Updated: Apr 29, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Candidate gene discovery and prioritization in rare diseases
1Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, ML 7024, Cincinnati, OH, 45229, USA, Anil.Jegga@cchmc.org.
Identifying candidate genes for rare diseases is challenging due to data overload and validation costs. This study presents in silico strategies and a web tool to prioritize potential disease genes using integrated data, aiding rare disease research.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Rare or orphan disorders affect a small population, with underlying genes and pathways often unknown.
- High-throughput sequencing advances generate vast data, creating a "data deluge" challenge for identifying disease candidate genes.
- Experimental validation of candidate genes is costly and time-consuming, necessitating computational approaches.
Purpose of the Study:
- To provide an overview of in silico strategies for candidate gene prioritization in rare disease research.
- To demonstrate the utility of a web-based computational suite for ranking disease candidate genes using integrated heterogeneous data sources.
Main Methods:
- Review of in silico strategies for candidate gene prioritization based on the guilt-by-association principle.
- Utilizing a web-based computational suite integrating diverse data sources for ranking candidate genes.
- Demonstration of typical query execution within the web tool for rare disease research.
Main Results:
- Computational approaches, particularly those using prior disease knowledge, aid in discovering and ranking novel candidate genes.
- The presented web-based tool effectively integrates heterogeneous data for candidate gene prioritization.
- The system demonstrates practical application in identifying promising candidates for rare disease research.
Conclusions:
- In silico candidate gene prioritization is crucial for efficient rare disease research, mitigating experimental costs and time.
- The described web-based tool offers a valuable resource for researchers by leveraging integrated data to rank candidate genes.
- This approach facilitates the identification of potential disease genes, advancing our understanding of rare disorders.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Incomplete Dominance
Single Nucleotide Polymorphisms-SNPs
Gene Therapy

